DENTSPLY SIRONA INC
XRAYNASDAQTrading Snapshot
- Day Range
- $8.87 β $9.13
- 52-Week Range
- $8.90 β $14.76
- Volume
- $4.59B
- Avg Volume
- $5.16B
- Shares Outstanding
- 200.3M
- Next Earnings
- Nov 30, 2026
Fundamentals Snapshot
- Annual Revenue
- $3.68B
- Last Q Revenue
- $898M
- P/E Ratio
- -3.3
- P/S Ratio
- 0.5x
- EPS (TTM)
- $-2.73
- Dividend Yield
- 3.56%
- Dilution (1yr)
- β1.8%
Why Investors Own XRAY
- βHigh-growth profile β revenue up +45.2% YoY with expanding US Equity exposure.
- βHealthy economics β 28% gross margin and 30% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
DENTSPLY SIRONA INC
XRAYAbout DENTSPLY SIRONA INC
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year Low β Time to Sell?
Shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report) hit a new 52-week low on Friday. The company traded as low as $9.36 and last traded at $9.38, with a volume of 9306449 shares. The stock had previously clos

Engineers Gate Manager LP Boosts Stake in DENTSPLY SIRONA Inc. $XRAY
Engineers Gate Manager LP boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 451.5% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.

XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.

Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket p

Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
CHARLOTTE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (βDentsply Sironaβ or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Baird 2026 Global Healthcare Conferenc